MedTrace Logo

Modified TAP (Transverse Abdominis Plane) Block in Colorectal Surgery

NCT04781075 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2021-09-10

No results posted yet for this study

Summary

Single Blind, Randomized Controlled study to see if TAP Block with Exparel provides better pain relief than TAP Block with bupivicaine. Differences in Pain Scale, Length of Stay, and Total Narcotic use in the hospital will be evaluated.

Conditions

  • Pain, Postoperative

Interventions

OTHER

Pain Scale

Maximum Daily Pain Scale will be recorded daily until discharge (typically under 7 days)

DRUG

Exparel Injectable Product

Given at the beginning of the surgery for post-operative pain management

DRUG

Bupivacaine Injection

Given at the beginning of the surgery for post-operative pain management

Sponsors & Collaborators

  • Ochsner Health System

    lead OTHER

Principal Investigators

  • Charles Whitlow, MD · Ochsner

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2020-12-31
Completion
2021-07-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04781075 on ClinicalTrials.gov